dobutamine has been researched along with digitoxin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Beuckelmann, D; Böhm, M; Brown, L; Erdmann, E; Feiler, G; Kemkes, B; Lorenz, B; Näbauer, M | 1 |
| Leier, CV | 1 |
| Applefeld, MM | 1 |
| Bardet, J; Bourdarias, JP; Dubourg, O; Ferrier, A; Gueret, P | 1 |
| Drummond, WH | 1 |
1 review(s) available for dobutamine and digitoxin
| Article | Year |
|---|---|
Inotropic agents in the treatment of cardiogenic shock.
Topics: Cardiac Output, Low; Cardiac Tamponade; Cardiotonic Agents; Catecholamines; Digitalis; Dobutamine; Dopamine; Glucagon; Humans; Isoproterenol; Metaraminol; Methoxamine; Myocardial Infarction; Norepinephrine; Phenylephrine; Plants, Medicinal; Plants, Toxic; Pulmonary Embolism; Shock, Cardiogenic | 1983 |
7 other study(ies) available for dobutamine and digitoxin
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Bucladesine; Calcium; Cardiac Output, Low; Cardiotonic Agents; Colforsin; Digitoxin; Digoxin; Dobutamine; Histamine; Humans; In Vitro Techniques; Middle Aged; Myocardial Contraction; Myocardium; Receptors, Adrenergic, beta; Stimulation, Chemical | 1988 |
General overview and update of positive inotropic therapy.
Topics: Amrinone; Blood Pressure; Cardiotonic Agents; Digitoxin; Dobutamine; Dopamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoproterenol; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Time Factors | 1986 |
Chronic congestive heart failure. Where have we been? Where are we heading?
Topics: Aminopyridines; Amrinone; Biopsy; Calcium Channel Blockers; Cardiology; Chronic Disease; Digitalis; Dobutamine; Dopamine; Forecasting; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Contraction; Myocardium; Plants, Medicinal; Plants, Toxic; Prognosis; Quality of Life; Vasodilator Agents | 1986 |
Use of cardiotonic therapy in the management of infants with PPHN.
Topics: Animals; Animals, Newborn; Cardiotonic Agents; Digitalis; Digoxin; Dobutamine; Dogs; Dopamine; Drug Therapy, Combination; Humans; Infant, Newborn; Isoproterenol; Persistent Fetal Circulation Syndrome; Plants, Medicinal; Plants, Toxic; Sheep; Swine | 1984 |